Results 121 to 130 of about 93,748 (310)
E6 Cessation of antihypertensive drug therapy: A meta-analysis [PDF]
W ELLIOTT
openalex +1 more source
Abstract Objective To compare the prevalence of pre‐eclampsia with and without severe features, and maternal and perinatal outcomes before and during the COVID‐19 pandemic. Methods Cross‐sectional study based on medical chart review of pregnant women admitted to a referral maternity hospital for childbirth between September 2019 to February 2020 ...
Juliana da‐Costa‐Santos +12 more
wiley +1 more source
Responses of the ambulatory arterial stiffness index and other measures of arterial function to antihypertensive drugs [PDF]
Yu Jin +9 more
openalex +1 more source
This systematic review investigated the association of prenatal exposure to antihypertensive medication with longer‐term poor neurodevelopmental outcomes by evaluating the findings from existing literature. We undertook a systematic review of previous studies looking specifically at neurodevelopmental outcomes in children.
Shrifah Alkhalaf +5 more
wiley +1 more source
Exploring the roles and impacts of pharmacists embedded in general practice: a scoping review
Abstract Background The role of the general practice pharmacist (GPP) in Australia is not yet clearly defined, and their clinical expertise remains underutilised in general practice settings. This may be attributed to a limited understanding of pharmacists' capabilities, which can hinder optimal GPP utilisation.
Christel Chandra +3 more
wiley +1 more source
Study of Prescribing Pattern of Antihypertensive Drugs and Evaluation of the Prescription with JNC 8 Guidelines in North Karnataka Hospital [PDF]
Ashok Kumar Malpani +3 more
openalex +1 more source
Abstract BACKGROUND Cardiovascular diseases, largely driven by hypertension, remain the leading cause of mortality worldwide. Angiotensin‐I‐converting enzyme (ACE) inhibition is a well‐established therapeutic approach; however, synthetic inhibitors are frequently associated with adverse effects.
Fátima Rubio‐Senent +5 more
wiley +1 more source
ABSTRACT Type 2 diabetes mellitus (T2DM) is associated with an increased risk of osteoporosis and fractures, and denosumab, a non‐kidney‐excreted antiresorptive medication, represents a viable alternative to bisphosphonates for osteoporosis treatment in patients with T2DM. This study aimed to investigate the association among denosumab adherence, renal
Yu‐Chuan Chang +7 more
wiley +1 more source

